Announcing VACUETTE SAFELINK – A Safe Connection

To provide an optimal solution for blood collection, Greiner Bio-One has developed the new VACUETTE® SAFELINK Holder. This sterile tube holder provides a safe, needleless option for blood collection procedures from a female luer port. The VACUETTE® SAFELINK provides a secure luer lock connection, making this holder a safe and easy-to-use accessory for transfer of... Read more

Roche’s Kadcyla cut the risk of disease recurring by half compared to Herceptin in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment

Basel, 05 December 2018 Roche’s Kadcyla cut the risk of disease recurring by half compared to Herceptin in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment At three years, 88.3% of people treated with Kadcyla in the adjuvant HER2-positive early breast cancer setting did not have their breast cancer return compared... Read more

Roche’s Hemlibra provided sustained bleed control in the largest pivotal study to date of children with haemophilia A with factor VIII inhibitors

Basel, 03 December 2018 Roche’s Hemlibra provided sustained bleed control in the largest pivotal study to date of children with haemophilia A with factor VIII inhibitors Nearly 77% of children receiving Hemlibra once weekly experienced zero treated bleeds Hemlibra once weekly reduced treated bleeds by 99% compared to prior bypassing agents in a prospective intra-patient... Read more

Longer-term follow-up data demonstrate sustained benefit of polatuzumab vedotin-based treatment in relapsed or refractory diffuse large B-cell lymphoma

Basel, 03 December 2018 Longer-term follow-up data demonstrate sustained benefit of polatuzumab vedotin-based treatment in relapsed or refractory diffuse large B-cell lymphoma Polatuzumab vedotin in combination with MabThera/Rituxan (rituximab) plus bendamustine more than doubled overall survival, compared to MabThera/Rituxan plus bendamustine alone in the phase Ib/II GO29365 study Polatuzumab vedotin has the potential to provide... Read more

Honeywell Announces Move Of Global Headquarters To Charlotte

MORRIS PLAINS, N.J., Nov. 30, 2018 /PRNewswire/ — Honeywell (NYSE: HON) today announced it will relocate its global corporate headquarters to Charlotte, North Carolina, a business- and family-friendly city close to several of Honeywell’s businesses in the Southeast United States. Honeywell also announced it will relocate the headquarters of its Safety and Productivity Solutions (SPS) business group from Fort Mill,... Read more

The solar cells of the future

Oak Ridge National Labs researchers use ZEISS ORION NanoFab SIMS to characterize perovskite photovoltaic films Customer Story Knowledge Solar cells made out of a perovskite-structured compound are the fastest-growing solar technology to date. Compared to traditional silicon solar cells, the raw materials used are cheap to produce, simple to manufacture, and their efficiencies are very... Read more

High performance geological investigation

ZEISS Mineralogic v1.6 offers a bumper range of new capabilities News The 7th instalment of ZEISS Mineralogic since the software was brought to the market in July 2014 represents a significant advancement in both features and productivity. ZEISS Mineralogic Mining for automated mineral analysis The software is already well known for providing quantitative mineralogy with... Read more

Bruker Introduces Light-Sheet Microscope for Imaging Optically Cleared Samples

New Luxendo MuVi SPIM CS Combines Light-Sheet Fluorescence Microscopy and Tissue Clearing Techniques SAN DIEGO, Nov. 5, 2018 /PRNewswire/ — At the 2018 Annual Meeting of the Society for Neuroscience, Bruker today announced the release of the Luxendo MuVi SPIM CS light-sheet fluorescence microscope for imaging optically cleared samples. The MuVi SPIM technology allows fast, long-term... Read more

GE Healthcare and Shirazi Trading host continuous educational workshops for Pakistan's leading cardiologists and radiologists

Islamabad, Pakistan; October 08, 2018: GE Healthcare (NYSE: GE), in collaboration with Shirazi Trading, held a series of Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Imaging workshops in Rawalpindi, Pakistan. The workshops, led by renowned cardiologist Dr. Saima Mushtaq, GE Healthcare’s Clinical Leaders for CT and MRI, Murat Karakoc and Dr. Ibrahim Elmogy, brought... Read more